TL;DR: Six published hospital series and one systematic review describe what happened to patients who had cosmetic surgery abroad and came home with a problem. Read together, they point at one finding that matters more than any league table of countries: the complications arrive after the patient has flown home. In a Zurich series of 109 patients the median time from the operation abroad to presentation was 15 days for early complications; in an Australian series it was 3.8 weeks; in a Texas series, 32 days. By then the operating surgeon is a continent away, and in the Texas series the authors noted that the unanticipated cost of treating the complication often exceeded the cost of the original operation. Korea does not appear in the destination lists of the facial-surgery review — but that is an absence of reported cases in six small studies, not evidence of safety, and we say so plainly below. The practical conclusion is not about the map. It is that the single variable a patient can actually control is whether the aftercare is arranged, named and written down before they fly. Medical Korea Service (Registered Facilitator for International Patients — Seoul Metropolitan Government, Reg. No. A-2014-01-01-1414, registered 23 July 2014) sets out below the five things we put in writing for every patient, and the evidence for why each one is on the list.
Why we wrote this one
Most articles about surgery abroad are written by someone with a stake in the answer. This one is too — we coordinate facelifts in Korea, so a reader is entitled to discount what we say about other destinations. That is exactly why this article contains almost no opinion of ours. It reports what independent hospital teams in Switzerland, Australia, the United States and a Tulane University review group found when they counted their own patients, and then it says honestly what those counts do and do not prove.
There is one number worth starting with, because it describes how the decision is usually made. In a two-centre Swiss study published in 2026, researchers interviewed patients who had been treated for complications after aesthetic surgery abroad and asked why they had gone. Lower cost accounted for 54 per cent. The influence of social media or friends accounted for 23 per cent — the same share as shorter waiting times (Andreoli and colleagues, J Plast Reconstr Aesthet Surg 2026). Nearly a quarter of the people in that complication cohort had chosen a surgeon in another country substantially on the strength of a feed.
What the published series actually report
According to PubMed, the following are the studies we could find that counted these patients rather than describing them anecdotally. We have set out each one's size and what it found, so you can weigh them yourself rather than take a summary on trust.
| Study | Where and how many | What they found |
|---|---|---|
| Raggio 2020 Systematic review (Tulane) | 6 retrospective studies, 31 patients who had facial rejuvenation abroad and had a complication | 25 of 26 listed patients (96%) female, ages 33–62. Procedures included blepharoplasty, facelift, rhinoplasty, chin lift, botulinum toxin and fillers. Complications included abscess, poor cosmesis, facial nerve palsy and death. The authors state plainly that no definitive conclusions can be drawn from so few patients |
| Klein 2017 University Hospital Zurich | 109 patients, 2010–2014, all female, mean age 38.5 | Infections 25.7%, wound breakdown 19.3%, pain or discomfort 14.7%. 34.8% were admitted, averaging 5.2 days. Median time to presentation: 15 days (early), 81.5 days (mid-term), 4.9 years (late) |
| Ross 2018 Brigham and Women's / Harvard | 78 patients over 7 years | Most common: abdominoplasty (35), breast augmentation (25), foreign-body injections (15). 18 had multiple procedures in a single operative setting. 86% relied on medical insurance to pay for treating the complication |
| Duggan 2024 UT Medical Branch, Galveston | 24 patients, all female, mean age 35.6 | Presented on average 32 days after the operation. All used emergency department resources; 20 of 24 were admitted, averaging 5.5 days; 15 needed a further procedure. The authors conclude the unanticipated cost of the complication often exceeds the cost of the original operation |
| Res 2026 Westmead Hospital, Sydney | 24 patients, 87.5% female, mean age 38.4 | Wound dehiscence 45.8%, infection 41.7%, seroma 20.8%. Median 3.8 weeks from surgery to presentation. 83.3% needed oral antibiotics, 58.3% intravenous antibiotics, 54.2% needed surgery. Half the cohort were smokers |
| Andreoli 2026 Two Swiss centres | 32 patients of 275 screened, 2020–2024; 53 operations across 10 countries | Infections 36%, wound dehiscence 28%, haematoma 8%. Those 32 patients required 42 revision operations. Treatment cost USD 691,838, borne by the Swiss healthcare system |
Two things stand out immediately. The first is that these are small numbers — 31, 109, 78, 24, 24, 32. The second is that they are consistent with one another anyway: infection and wound breakdown dominate every series, and a large minority of patients needed another operation to fix the first one.
The finding that matters most: the clock starts after you land
Line up the timing figures from the three series that reported them and a pattern appears that no brochure mentions.
| Series | Typical time from operation to presenting with the problem | Where the patient was by then |
|---|---|---|
| Klein 2017 (Zurich) | Median 15 days for early complications; 81.5 days for mid-term | Home, in another country |
| Res 2026 (Sydney) | Median 3.8 weeks | Home, in another country |
| Duggan 2024 (Texas) | Mean 32 days | Home; all 24 went to an emergency department |
Almost nobody in these studies developed their problem while still abroad and under the care of the surgeon who operated. They developed it two to five weeks later, at home, and presented to a hospital that had no operative record, no implant details, no photographs and no relationship with the surgeon. The Texas authors put the consequence in one sentence: surgical tourism leaves the patient to find appropriate post-operative care with their surgeon some hundreds of miles away.
This reframes the question a patient should be asking. "Is this country safe?" is largely unanswerable from the published evidence. "Who treats me in week three, and does that person have my operative record?" is answerable before you book — and the studies suggest it is the question that determines how a complication ends.
The infection that hides for months
One complication deserves separate treatment because its timeline defeats the usual assumption that if you feel well after two weeks you are fine. Rapidly growing mycobacteria — most often Mycobacterium abscessus — are environmental organisms found in water supplies, and they cause surgical-site infections when instruments or water used in theatre are inadequately sterilised.
A Johns Hopkins and University of Maryland team described the pattern: the incubation period can run to months, the presenting signs are purulent drainage, violaceous nodules and subcutaneous abscesses at the surgical site, and the diagnostic giveaway is that the infection persists despite debridement and ordinary antibiotics. Treatment is surgical drainage plus a multi-drug regimen typically including amikacin, a macrolide and a carbapenem or cephalosporin — months of therapy, not a week of tablets (Leto Barone and colleagues, Ann Plast Surg 2020). A Montefiore Medical Center team in the Bronx reported four culture-proven cases in returning medical tourists over an eleven-month period, all requiring aggressive surgical treatment alongside antibiotics (Cusumano and colleagues, Int J Infect Dis 2017).
The practical point for a patient is narrow and useful: a wound problem that appears weeks or months after surgery abroad, and that does not respond to a standard antibiotic course, should prompt the treating doctor to consider mycobacterial culture on specific growth media. Patients who do not know this can spend months on the wrong treatment.
Which countries appear — and what Korea's absence does not mean
The destination countries named across these papers are, in the facial-surgery review: the Dominican Republic, Cyprus, the United States, Colombia, Thailand, India and China. In the Texas series: Mexico (10 of 12 international cases) and the Dominican Republic — with Miami accounting for 8 of 12 domestic cases. In the Zurich series: South America 43 per cent, south-eastern Europe 29.4 per cent, central Europe 24.8 per cent.
Korea does not appear in those lists. We are not going to make the argument you might expect us to make from that, because it would not be sound, and readers who check our sources would catch it. Here is what the absence actually means and does not mean:
- What it means: across six small retrospective studies of facial-rejuvenation complications, no reported case had travelled to Korea. That is a real observation and it is not nothing.
- What it does not mean: that complications do not happen in Korea. They do — a facelift is a large operation and every series of facelifts, including Korean ones, reports haematomas, infections and revisions. These papers counted patients who returned to a handful of specific Western hospitals. A patient from Jakarta or Singapore who has a problem after surgery in Seoul returns to Jakarta or Singapore, where no one is publishing a case series in English. Absence of reported cases in six studies is not evidence of absence.
Two further details cut against any simple map-based reading. The United States appears as a destination in the facial review, and the largest single cluster in the Texas study was domestic travel to Miami. Patients were not harmed because they crossed a border into a poorer country; they were harmed because they had an operation far from anyone who would take responsibility for the weeks afterwards. The variable is the aftercare gap, not the passport stamp.
What these numbers cannot tell you — stated plainly
We would rather lose a reader's business than their trust, so the limits are here rather than in a footnote.
- There is no denominator. Every study counted patients who had a complication. None of them knows how many people travelled and were fine. You cannot calculate a risk rate from any figure on this page, and anyone who quotes you one from these papers is misusing them.
- The samples are small and the review says so itself. The Tulane authors wrote that no definitive conclusions can be made given the paucity of data, its heterogeneity and the small sample size. We are quoting them accurately, including that sentence.
- Most of the body-contouring data is not facial surgery. The Zurich, Harvard, Texas and Sydney series are dominated by abdominoplasty, liposuction and breast surgery. Only the Tulane review is specifically facial. The timing finding is the part that transfers; the procedure mix does not.
- Referral bias runs through all of it. These are the patients who presented to large public or academic hospitals. Patients whose problems were minor, or who went back to the original surgeon, are invisible in this literature.
The five things to have in writing before you fly
Everything above converges on a short, checkable list. None of it requires trusting us — a patient can demand these from any clinic in any country, and the answer they get is itself informative.
| # | What to have in writing | Which finding it answers |
|---|---|---|
| 1 | The operative record in English — named surgeon, exact procedure performed, anaesthesia used, implants or materials with lot numbers, and the date — handed to you before you leave the country | Patients present at home two to five weeks later to a hospital with no record of what was done |
| 2 | A named person and a working number for weeks 2 to 12, in a language you speak, with an answer to "what happens if I message on a Sunday" | Median 15 days, 3.8 weeks, 32 days — every reported timeline lands after you are home |
| 3 | A written revision policy: who pays, who operates, and whether you must return to the original country for it to apply | 32 Swiss patients required 42 revision operations; 54.2% of the Sydney cohort needed surgery |
| 4 | A named local doctor at home who has agreed in advance to see you if something goes wrong, with your operative record sent to them | All 24 Texas patients went through an emergency department; 86% of the Harvard cohort fell back on insurance |
| 5 | A written warning-signs list with a "months, not weeks" line on it — including that a late, treatment-resistant wound infection needs mycobacterial culture | M. abscessus incubation can run to months and persists through ordinary antibiotics |
If a clinic cannot produce items 1, 2 and 3 in writing before you pay a deposit, that is the finding. It is not a judgement about the country it is in.
How we handle this
Medical Korea Service is a registered facilitator, not a clinic. We do not operate and we do not own a hospital, which means our role is precisely the gap these studies describe: the part that happens before you fly and after you land. We match patients to specialists from a verified list, and the verification standard — the public checks anyone can repeat, including the Korean Society of Plastic and Reconstructive Surgeons register, HIRA and the consent-form and CCTV provisions of Korean law — is set out in full in How we verify Korean plastic surgeons. Items 1 to 3 above are obtained from the clinic in writing as part of that process, in English or Bahasa Indonesia, before a surgery date is fixed.
We are candid about the boundary of what a facilitator can do. We cannot guarantee that no complication occurs; no one honestly can. What the list above changes is not the probability of a problem — it is whether, on day 21, in your own city, there is a named person, a written record and an agreed plan, or a phone number in another time zone that nobody answers.
Frequently asked questions
How common are complications after cosmetic surgery abroad?
Nobody knows, and the published studies cannot tell you. Every series described here counted only patients who came back with a problem; none of them recorded how many people travelled in total. That means there is no denominator and therefore no valid percentage. Any article that gives you a complication rate for "surgery abroad" from this literature has misread it.
When do complications after surgery abroad usually appear?
After the patient has flown home. The median time from operation to presentation was 15 days for early complications in a 109-patient Zurich series, 3.8 weeks in a 24-patient Sydney series, and a mean of 32 days in a 24-patient Texas series. This is why arranging aftercare at home before you travel matters more than almost anything else on a pre-surgery checklist.
Is Korea safer than other destinations for facial surgery?
We cannot prove that from the published evidence, and we will not claim it. Korea does not appear in the destination lists of the six studies reviewed by the Tulane group, but those studies counted patients returning to specific Western hospitals, so the absence reflects who was counted rather than where surgery is safe. Complications occur in Korea as they do everywhere. Judge a specific surgeon and a specific aftercare arrangement, not a country.
What should I do if a wound problem appears weeks after surgery abroad?
See a doctor at home promptly and tell them explicitly that you had surgery overseas and when. If the infection does not settle on a standard antibiotic course, ask whether mycobacterial culture on specific growth media is warranted — rapidly growing mycobacteria have an incubation period that can run to months and characteristically persist through ordinary antibiotics and debridement. Bring your operative record to that appointment.
What is the single most useful question to ask a clinic abroad?
"Who treats me in week three, and will they have my operative record?" It is checkable, it is answerable in writing, and the published timelines show week three is when the problem actually arrives.
Related reading: Ghost surgery in Korea: the CCTV law and how to make sure your surgeon operates · How we verify Korean plastic surgeons — the 24-criteria standard · Before a facelift in Korea: anaesthesia, medications to stop and what to bring · Day-by-day recovery and when it is safe to fly home · Why Asian faces need a different facelift plan · Facelift in Korea — how we match you to a verified specialist
This article was prepared by Medical Korea Service as general information for patients considering facial surgery outside their home country. It is not medical advice and does not replace the written instructions of your surgeon or treating physician, which govern in every case. All study figures are quoted from the peer-reviewed sources linked in the text, retrieved from PubMed; where authors stated limitations on their own findings, those statements are reproduced above. The studies cited counted patients presenting with complications and contain no denominator, so no complication rate can be derived from them. No patient is identifiable and no clinic or surgeon is named.